Dupilumab Gains Pediatric CSU Approval - Poll - MDSpire

Dupilumab Gains Pediatric CSU Approval

Targets type 2 inflammation in a population with limited treatment options

  • By

  • Kathryn Wighton

  • April 24, 2026

  • 2 min

Share

Original Source(s)

Dupilumab Gains Pediatric CSU Approval

  • by Kathryn Wighton

  • April 24, 2026

Related Content

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.

Correction: Measuring mental wellbeing in clinical and non-clinical adolescents using the COMPAS-W Wellbeing Scale

Partly intraoperative cell salvage in pediatric craniocerebral trauma: effects on coagulation function, allogeneic blood requirements, and clinical outcomes — a propensity score-matched retrospective cohort study